These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7178020)

  • 21. The TIMI story.
    Taylor J
    Eur Heart J; 2011 Dec; 32(24):3062-3a. PubMed ID: 22276306
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment of myocardial infarction with ST-segment elevation].
    Mohácsi A; Edes I; Czuriga I
    Orv Hetil; 2004 Feb; 145(6):297-300. PubMed ID: 15038323
    [No Abstract]   [Full Text] [Related]  

  • 23. Randomized comparison of a novel anticoagulant, vasoflux, and heparin as adjunctive therapy to streptokinase for acute myocardial infarction: results of the VITAL study (Vasoflux International Trial for Acute Myocardial Infarction Lysis).
    Peters RJ; Spickler W; Théroux P; White H; Gibson M; Molhoek PG; Anderson HV; Weitz JI; Hirsh J; Weaver WD
    Am Heart J; 2001 Aug; 142(2):237-43. PubMed ID: 11479461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical impact of local implementation of agreed guidelines for the management of patients with acute myocardial infarction.
    Badano L; Cassin M; Solinas L; Burelli C; Macor F; Zanuttini D
    G Ital Cardiol; 1999 Jan; 29(1):39-47. PubMed ID: 9987046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Strategies to improve reperfusion with fibrinolytic therapy in ST-T elevation myocardial infarction].
    Jerjes-Sánchez C; Sosa del Angel E; García Sosa A; Reyes Cerezo E; Garza Ruiz A
    Arch Cardiol Mex; 2003; 73(1):46-58. PubMed ID: 12820494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Future developments in thrombolytic therapy].
    Bode C; Runge MS
    Z Kardiol; 1993; 82 Suppl 2():187-90. PubMed ID: 8328201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antithrombotic therapy for unstable angina in non-q myocardial infarct].
    Lorenzoni R; Gensini GF; De Caterina R
    G Ital Cardiol; 1998 Apr; 28(4):468-80. PubMed ID: 9616862
    [No Abstract]   [Full Text] [Related]  

  • 28. Evolving antithrombotic treatment strategies for acute ST-elevation myocardial infarction.
    Kandzari DE
    Rev Cardiovasc Med; 2006; 7 Suppl 4():S29-37. PubMed ID: 17224888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fibrinolytic therapy for acute ST-segment elevation myocardial infarction.
    Kerigan A
    CMAJ; 2002 Mar; 166(6):708; author reply 708, 710. PubMed ID: 11944752
    [No Abstract]   [Full Text] [Related]  

  • 30. Aspirin after thrombolysis for MI.
    Seaton TL
    J Fam Pract; 1997 Mar; 44(3):249-50. PubMed ID: 9071241
    [No Abstract]   [Full Text] [Related]  

  • 31. [Pharmacological thrombolysis in acute myocardial infarction. Lessons learned from ISIS-2 and GUSTO-1. I].
    Jerjes-Sánchez C; Garza-Ruiz A; Gutiérrez-Fajardo P
    Arch Inst Cardiol Mex; 1999; 69(5):478-87. PubMed ID: 10640212
    [No Abstract]   [Full Text] [Related]  

  • 32. Thrombolytic therapy for women in myocardial infarction. Different prognosis?
    Morais J
    Rev Port Cardiol; 1999; 18 Suppl 3():III27-30. PubMed ID: 10574020
    [No Abstract]   [Full Text] [Related]  

  • 33. [Fibrinolytic therapy in acute myocardial infarction].
    Shinar E; Hasin Y; Eldor A; Gotsman MS
    Harefuah; 1982 May; 102(9):393-5. PubMed ID: 7160733
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of myocardial infarction: hypotensive effect of different thrombolytic agents.
    Puletti M; Staropoli P; Curione M; Matteoli S; Trappolini M; Coppola A
    Riv Eur Sci Med Farmacol; 1994; 16(5-6):113-8. PubMed ID: 7480969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A cost-effectiveness analysis of aspirin versus oral anticoagulants after acute myocardial infarction in Italy -- equivalence of costs as a possible case for oral anticoagulants.
    Gianetti J; Gensini G; De Caterina R
    Thromb Haemost; 1998 Dec; 80(6):887-93. PubMed ID: 9869155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evolving role of low-molecular-weight heparins in ST-elevation myocardial infarction.
    Kalus JS; Moser LR
    Ann Pharmacother; 2005 Mar; 39(3):481-91. PubMed ID: 15701782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Thrombolytic therapy in myocardial infarction and older patients].
    Müller-Ehmsen J
    Dtsch Med Wochenschr; 2001 Sep; 126(38):1058-9. PubMed ID: 11565061
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmacoinvasive therapy: the future of treatment for ST-elevation myocardial infarction.
    Antman EM; Van de Werf F
    Circulation; 2004 Jun; 109(21):2480-6. PubMed ID: 15173037
    [No Abstract]   [Full Text] [Related]  

  • 39. The present and future of heparin, low molecular weight heparins, pentasaccharide, and hirudin for venous thromboembolism and acute coronary syndromes.
    Haas S
    Semin Vasc Med; 2003 May; 3(2):139-46. PubMed ID: 15199477
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Use of heparin in acute myocardial infarction in routine clinical practice in Germany. Results of the MITRA and MIR registries].
    Frilling B; Schiele R; Zahn R; Fischer F; Schneider S; Gitt AK; Heer T; Gottwik M; Glunz HG; Gieseler U; Baumgärtel B; Asbeck F; Senges J;
    Z Kardiol; 2002 Feb; 91(2):131-8. PubMed ID: 11963730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.